tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
iBio, AstralBio unveil obesity program with amylin receptor agonist antibody
PremiumThe FlyiBio, AstralBio unveil obesity program with amylin receptor agonist antibody
1M ago
iBio Extends Promissory Note Maturity to 2026
Premium
Company Announcements
iBio Extends Promissory Note Maturity to 2026
2M ago
iBio initiates non-human primate study of IBIO-610
Premium
The Fly
iBio initiates non-human primate study of IBIO-610
2M ago
iBio Enters Licensing Agreement for Obesity Treatment
PremiumCompany AnnouncementsiBio Enters Licensing Agreement for Obesity Treatment
3M ago
iBio announces licensing agreement with AstralBio
Premium
The Fly
iBio announces licensing agreement with AstralBio
3M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
iBio, Inc. Advances in Therapeutics and Leadership
Premium
Company Announcements
iBio, Inc. Advances in Therapeutics and Leadership
5M ago
iBio to transfer listing to Nasdaq from NYSE
Premium
The Fly
iBio to transfer listing to Nasdaq from NYSE
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100